Molecular variation between the α-toxins from the type strain (NCTC 8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals

References

1. Baba E., Fuller A.L., Gilbert J. M., Thayer S. G., McDougald J. M. 1992; Effects of Eimeria brunetti infection on necrotic enteritis in broiler chickens. Avian Dis 36:59–62
   [Google Scholar]
2. Basak A., Fearn A. M., Kelly D.C., Bishop D. H.L., Stuart D. I., Titball R. W. 1994; Purification and crystallisation of the alpha-toxin (phospholipase C) of Clostridium perfringens. J Mol Biol 244:648–650
   [Google Scholar]
3. Calmels D. 1982; Mise en évidence et titrage de la toxins alpha de Clostridium perfringens par diffusion radiale. Maladies Animates Causées par des Bactéries Anaérobies. Quatrième Symposium de l' Office International des Enzooties205–216 Paris: Office International des Enzootics;
   [Google Scholar]
4. Cunningham L. 1965; The acetylation of creatine phosphokinase with p-nitrophenyl acetate. Biochemistry 4:2637–2643
   [Google Scholar]
5. Cygan Z., Buczek J. 1993; Nonenterotoxigenic anaerobe C. perfringens A as a cause of calf diarrhoea. Med Weter 49:469–471
   [Google Scholar]
6. Darke S. G., King A. M., Slack W. K. 1977; Gas gangrene and related infection: classification, clinical features and etiology, management and mortality. A report of 88 cases. Br J Surg 64:104–112
   [Google Scholar]
7. Daube G. 1993 Typage moléculaire de Clostridium perfringens. Application a fétude de l enterotoxémie bovine DVS thesis Universite de Liege: Belgium;
   [Google Scholar]
8. Fujii Y., Sakurai J. 1989; Contraction of the rat isolated aorta caused by Clostridium perfringens alpha toxin (phospholipase C); evidence for the involvement of arachidonic acid metabolism. Br J Pharmacol 97:119–124
   [Google Scholar]
9. Fujii Y., Nomura S., Oshita Y., Sakurai J. 1986; Excitatory effect of Clostridium perfringens alpha toxin on the rat isolated aorta. Br J Pharmacol 88:531–539
   [Google Scholar]
10. Hubl W., Mostbeck B., Hartleb H., Pointer H., Kofler K., Bayer P. M. 1993; Investigation of the pathogenesis of massive hemolysis in a case of Clostridium perfringens septicemia. Ann Hematol 64:145–147
    [Google Scholar]
11. Hunter S. E.C., Brown J. E., Oyston P. C. F., Sakurai J., Titball R. W. 1993; Molecular genetic analysis of the beta-toxin of Clostridium perfringens reveals sequence homology with the alpha-toxin, gamma-toxin, and leukocidin of Staphylococcus aureus. Infect Immun 61:3958–3965
    [Google Scholar]
12. Johannsen U., Arnold P., Köhler B., Selbitz H. J. 1993; Untersuchungen zur experimentelen Clostridium-perfringens-Typ-A-Enterotoxämie der Saugferkel. Monh Vet Med 48:129–136
    [Google Scholar]
13. Katayama S. -L., Matsushita O., Minami J., Mizobuchi S., Okabe A. 1993; Comparison of the alpha-toxin genes of Clostridium perfringens type A and type C strains: evidence for extragenic control of transcription. Infect Immun 61:457–463
    [Google Scholar]
14. Kohler G., Milstein C. 1975; Continuous culture of fused cells secreting antibody of predefined specificity. Nature 256:495–497
    [Google Scholar]
15. Lappointe J.-R., Fredette V. 1975; Mutant attenue nitro-soguanidine-induit dans la gangrene gazeuse a Clostridium perfringens type A. Can J Microbiol 21:1259–1269
    [Google Scholar]
16. Leslie D., Fairweather N., Pickard D., Dougan G., Kehoe M. 1989; Phospholipase C and haemolytic activities of Clostridium perfringens α-toxin cloned in Escherichia coli; sequence and homology with a Bacillus cereus phospholipase C. Mol Microbiol 3:383–392
    [Google Scholar]
17. Logan A. J., Williamson E. D., Titball R. W., Percival D. A., Shuttleworth A. D., Conlan J. W., Kelly D. C. 1991; Epitope mapping of the α-toxin of Clostridium perfringens. Infect Immun 59:4338–4342
    [Google Scholar]
18. Long J. R., Truscott R. B. 1976; Necrotic enteritis in broiler chickens. III. Reproduction of the disease. Can J Comp Med 40:53–59
    [Google Scholar]
19. Marmur J. 1961; A procedure for the isolation of deoxyribonucleic acid from micro-organisms. J Mol Biol 3:208–218
    [Google Scholar]
20. McDonel J. L. 1986; Toxins of Clostridium perfringens types A, B, C, D and E. Pharmacology of Bacterial Toxins477–517 Edited by Dorner F., Drews J. Oxford: Pergamon Press;
    [Google Scholar]
21. Möllby R. 1978; Bacterial phospholipases. Bacterial Toxins and Cell Membranes367–424 Edited by Jeljaszewicz J., Wadstrom T. London: Academic Press;
    [Google Scholar]
22. Möllby R., Holme T., Nord C.E., Smyth C. J., Wadström T. 1976; Production of phospholipase C (α-toxin), haemolysins and lethal toxins by Clostridium perfringens types A to D. J Gen Microbiol 96:137–144
    [Google Scholar]
23. Ninomiya M., Matsushita O., Minami J., Sakamoto H., Nakano M., Okabe A. 1994; Role of alpha-toxin in Clostridium perfringens infection determined by using recombinants of C. perfringens and Bacillus subtilis. Infect Immun 62:5032–5039
    [Google Scholar]
24. Okabe A., Shimizu T., Hayashi H. 1989; Cloning and sequencing of a phospholipase C gene of Clostridium perfringens. Biochem Biophys Res Commun 160:33–39
    [Google Scholar]
25. Saint-Joanis B., Gamier T., Cole S. 1989; Gene cloning shows the α-toxin of Clostridium perfringens to contain both sphingomyelinase and lecithinase activities. Mol & Gen Genet 219:453–460
    [Google Scholar]
26. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: a Laboratory Manual, 2nd edn.. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
27. Sato H., Yamakawa Y., Ito A., Murata R. 1978; Effect of zinc and calcium ions on the production of alpha-toxin and proteases by Clostridium perfringens. Infect Immun 20:325–333
    [Google Scholar]
28. Sato H., Chiba J., Sato Y. 1989; Monoclonal antibodies against alpha toxin of Clostridium perfringens. FEMS Microbiol Lett 59:173–176
    [Google Scholar]
29. Stevens D.L., Maier K. A., Laine B. M., Mitten J. E. 1987; Comparison of clindamycin, rifampicin, tetracycline, metronidazole and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens. J Infect Dis 155:220–228
    [Google Scholar]
30. Titball R. W. 1993; Bacterial phospholipases C. Microbiol Rev 57:347–366
    [Google Scholar]
31. Titball R. W., Hunter S. E.C., Martin K.L., Morris B.C., Shuttleworth A. D., Rubidge T., Anderson D. W., Kelly D. C. 1989; Molecular cloning and nucleotide sequence of the α-toxin (phospholipase C) of Clostridium perfringens. Infect Immun 57:367–376
    [Google Scholar]
32. Titball R. W., Leslie D.L., Harvey S., Kelly D. C. 1991; Hemolytic and sphingomyelinase activities of Clostridium perfringens α-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway. Infect Immun 59:1872–1874
    [Google Scholar]
33. Titball R. W., Fearn A. M., Williamson E. D. 1993; Biochemical and immunological properties of the C-terminal domain of the α-toxin of Clostridium perfringens. FEMS Microbiol Lett 110:45–50
    [Google Scholar]
34. Tso J. Y., Siebel C. 1989; Cloning and expression of the phospholipase C gene from Clostridium perfringens and Clostridium bifermentans. Infect Immun 57:468–476
    [Google Scholar]
35. Van Damme-Jongsten M., Wernars K., Notermans S. 1989; Cloning and sequencing of the Clostridium perfringens enterotoxin gene. Antonie Leeuwenhoek 56:181–190
    [Google Scholar]
36. Wadstrom T. 1978; Advances in the purification of some bacterial protein toxins. Bacterial Toxins and Cell Membranes9–57 Edited by Jeljaszewicz J., Wadstrom T. London: Academic Press;
    [Google Scholar]
37. Williamson E. D., Titball R. W. 1993; A genetically engineered vaccine against the α-toxin of Clostridium perfringens also protects mice against experimental gas gangrene. Vaccine 11:1253–1258
    [Google Scholar]